Eu Ivdd Eu Ivd Annex 2 List B On The Market 🇨🇳 China

CancerCheck ® fPSA

Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
06974404980036
Basic UDI-DI Code
B-06974404980036
Reference
K32-FPSA
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
On The Market

Additional Description

The CancerCheck® fPSA rapid test is a chromatographic immunoassay for the quantitative detection of free prostate-specific antigen in human serum or plasma. Free PSA in combination with PSA testing is a screening tool for early detection of prostate cancer. It is not automated and the testing population is adult male. This in vitro diagnostic rapid test is only for professional use in clinical units or doctor´s offices.

CND Nomenclature Codes

Code Description
W0102030114 FREE PROSTATIC SPECIFIC ANTIGEN

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) No. V1 061788 0008

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all